This is the body of the mini event series
Health Policy Roundup: Background on FDA User Fee Programs
This event was Part IV of the Alliance’s Health Policy Roundup and 2022 Forecast series. Download a summary of this event » Since the passage of the first User Fee Act in 1992, user fee programs have helped finance the Food and Drug Administration (FDA)’s review of human medical products such as drugs and medical devices. By authorizing the collection of user […]